Tucatinib 150 Mg Tablet

 is a medicine used to treat a specific type of breast cancer called HER2-positive breast cancer, especially when it has spread to other parts of the body, including the brain. It is usually given along with two other medicines—trastuzumab and capecitabine.

Tucatinib in Tucanat 150mg Tablet works by blocking a protein (HER2) that helps cancer cells grow. By doing this, Tucatinib helps slow down or stop the cancer from spreading further.

Tucatinib is not a chemotherapy drug. It is a targeted therapy, which means it attacks cancer cells more specifically and causes less harm to healthy cells. It is given only with a doctor’s advice and regular checkups are needed during treatment to make sure the medicine is working safely.

Tucanat 150mg Tablet is used for:

• HER2-positive advanced or metastatic breast cancer

• Brain metastases in HER2+ breast cancer patients

• Use in combination with trastuzumab and capecitabine after previous HER2-directed therapies

This therapy is typically considered when other standard HER2 treatments have become ineffective.